Interstitial lung diseases (ILD) are part of a large heterogeneous group of diseases that differ in many ways (in their cause, clinical presentation, and response to therapy, etc.), but there are similar pathophysiological mechanisms involved in the development of the inflammation and/or fibrosis of the lungs. Currently, several criteria for pulmonary fibrosis (PF) and progressive pulmonary fibrosis (PPF) are proposed, and the information on the prevalence and characteristics of these conditions is limited. The aim of this study was to evaluate the spectrum of PF and PPF according to the registry of patients with ILD in eastern Siberia. Materials and methods: The study included patients with ILD from all of the medical institutions in the I...
Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but an ac...
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) ...
International audienceIn patients with chronic fibrosing interstitial lung disease (ILD), a progress...
The concept of progressive fibrosing interstitial lung disease (PF-ILD) has recently emerged. Howeve...
A proportion of patients with interstitial lung diseases can also develop a progressive-fibrosing ph...
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has increased...
Abstract A proportion of patients with certain types of interstitial lung disease (ILD), including c...
Abstract Background The progressive fibrosing (PF) phenotype of interstitial lung disease (ILD) is c...
A number of patients with interstitial lung diseases (ILD) of various etiologies, including hypersen...
There are over 200 interstitial lung diseases (ILDs). In addition to patients with idiopathic pulmon...
A registry of patients with idiopathic pulmonary fibrosis (IPF) was founded in Russia in 2016. The a...
Background: Progressive fibrosis can occur in connective tissue disease (CTD)-related interstitial l...
Idiopathic pulmonary fibrosis (IPF) plays a special role within the group of interstitial lung disea...
Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who have ...
Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who have ...
Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but an ac...
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) ...
International audienceIn patients with chronic fibrosing interstitial lung disease (ILD), a progress...
The concept of progressive fibrosing interstitial lung disease (PF-ILD) has recently emerged. Howeve...
A proportion of patients with interstitial lung diseases can also develop a progressive-fibrosing ph...
The availability of epidemiological data relating to interstitial lung diseases (ILDs) has increased...
Abstract A proportion of patients with certain types of interstitial lung disease (ILD), including c...
Abstract Background The progressive fibrosing (PF) phenotype of interstitial lung disease (ILD) is c...
A number of patients with interstitial lung diseases (ILD) of various etiologies, including hypersen...
There are over 200 interstitial lung diseases (ILDs). In addition to patients with idiopathic pulmon...
A registry of patients with idiopathic pulmonary fibrosis (IPF) was founded in Russia in 2016. The a...
Background: Progressive fibrosis can occur in connective tissue disease (CTD)-related interstitial l...
Idiopathic pulmonary fibrosis (IPF) plays a special role within the group of interstitial lung disea...
Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who have ...
Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who have ...
Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but an ac...
Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) ...
International audienceIn patients with chronic fibrosing interstitial lung disease (ILD), a progress...